Gcap14 Activators are a diverse class of chemical compounds that indirectly influence the activity of Gcap14 by modulating various signaling pathways and cellular processes. These activators work by either increasing the levels of second messengers like cAMP, which in turn activate kinases like PKA, or by inhibiting phosphatases that would otherwise dephosphorylate and deactivate proteins within signaling pathways. For instance, forskolin, by directly stimulating adenylate cyclase, raises cAMP levels, which leads to the activation of PKA-a kinase that may target Gcap14 or its associated regulatory proteins. On the other hand, compounds like okadaic acid and calyculin A inhibit protein phosphatases 1 and 2A, maintaining proteins in a phosphorylated state, which can influence the activity of Gcap14.
The specificity of these activators in regard to Gcap14 is not well-defined, as they act on broader cellular pathways that may impact a range of proteins. Nonetheless, the alterations in phosphorylation patterns and second messenger levels brought about by these compounds can potentially modulate the activity of Gcap14, albeit in an indirect manner. The functional mechanisms of these activators are diverse, ranging from alterations in kinase and phosphatase activity to shifts in cellular energy balance and second messenger dynamics. Each chemical's mode of action, whether it is through fostering or sustaining a phosphorylated state of proteins, or through modifying the concentrations of intracellular signaling molecules, presents a unique route through which Gcap14 activity could be modulated.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing cAMP levels. Elevated cAMP can activate PKA, which may phosphorylate Gcap14, altering its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing cAMP degradation, thus potentially enhancing PKA activity and subsequent phosphorylation of Gcap14. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which could phosphorylate Gcap14 or related regulatory proteins, influencing Gcap14 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits GSK-3, indirectly stabilizing proteins and potentially enhancing activity of Gcap14 through downstream signaling cascades. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
As a non-specific phosphorylation activator, sodium fluoride may activate kinases that phosphorylate Gcap14, modulating its function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation levels within the cell, potentially affecting Gcap14 activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A specifically inhibits protein phosphatases 1 and 2A, which may result in increased phosphorylation and activation of Gcap14. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can lead to phosphorylation of various proteins and might indirectly activate Gcap14 through altering cellular energy balance. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that elevates cAMP levels, potentially enhancing PKA activity and phosphorylation of Gcap14. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a PKC inhibitor that, by inhibiting PKC, may alter the phosphorylation status of Gcap14 through feedback loops or cross-talk with other kinases. | ||||||